e-Drug3D 1639 |
cas 72490-81-4 |
CLASS ANTINEOPLASTIC |
ROUTE (list) - |
ATC code |
PK parameters Cmax 86.5 MICROMOLAR |
Target TARGET DNA |
DrugCentral Unknown |
Download SDF file | 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-beta-D-arabinofuranosyl]- Formula: Calculated chemical properties: MW 519.16 NB_atoms 32 XLogP -4.45 PSA 285.943 NB_HD 5 NB_HA 19 fsp3 0.50 Lipinski(0=no;1=yes) 0 |
FDA - |
Other links: | |
e-Drug3D 940 |
cas 121032-29-9 |
CLASS ANTINEOPLASTIC |
ROUTE (list) INTRAVENOUS |
ATC code |
PK parameters Cmax 16.8 MICROMOLAR Solubility SLIGHTLY SOLUBLE TO SOLUBLE IN WATER |
Target TARGET ADENOSINE DEAMINASE |
DrugCentral Unknown |
Download SDF file | (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Formula: Calculated chemical properties: MW 297.28 NB_atoms 21 XLogP -1.97 PSA 142.218 NB_HD 5 NB_HA 10 fsp3 0.55 Lipinski(0=no;1=yes) 0 |
FDA NDA 021877 (label) INN (NELARABINE) ARRANON (SANDOZ) APPROVAL= AP YEAR= 2005 NEWMOLECULARENTITY NDA 215037 (pdf not found) INN (NELARABINE) NELARABINE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2021 NDA 216934 (pdf not found) INN (NELARABINE) NELARABINE (DR REDDYS) APPROVAL= AP YEAR= 2022 NDA 214809 (pdf not found) INN (NELARABINE) NELARABINE (SHORLA) APPROVAL= AP YEAR= 2023 NDA 215057 (pdf not found) INN (NELARABINE) NELARABINE (NEXUS) APPROVAL= AP YEAR= 2023 NDA 216038 (pdf not found) INN (NELARABINE) NELARABINE (MEITHEAL) APPROVAL= AP YEAR= 2023 NDA 216346 (pdf not found) INN (NELARABINE) NELARABINE (AMNEAL) APPROVAL= AP YEAR= 2023 NDA 212605 (pdf not found) INN (NELARABINE) NELARABINE (GLAND) APPROVAL= AP YEAR= 2024 NDA 216510 (pdf not found) INN (NELARABINE) NELARABINE (XGEN PHARMS) APPROVAL= AP YEAR= 2024 NDA 216948 (pdf not found) INN (NELARABINE) NELARABINE (MSN) APPROVAL= AP YEAR= 2024 NDA 218554 (pdf not found) INN (NELARABINE) NELARABINE (ALEMBIC) APPROVAL= AP YEAR= 2024 |
Other links: |